Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Amélie Fouqué"'
Autor:
Hariniaina Rampanarivo, Mickael Jean, Amélie Fouqué, Patrick Legembre, Mac Dinh Hung, Kenji F. Shoji, Yves Collette, Marine Malleter, Rémy Castellano, Emmanuelle Josselin, Pierre van de Weghe, Olivier Delalande
Publikováno v:
Journal of Medicinal Chemistry
Journal of Medicinal Chemistry, 2019, 62 (20), pp.9339-9340. ⟨10.1021/acs.jmedchem.9b01578⟩
Journal of Medicinal Chemistry, American Chemical Society, 2019, 62 (20), pp.9339-9340. ⟨10.1021/acs.jmedchem.9b01578⟩
Journal of Medicinal Chemistry, 2019, 62 (20), pp.9339-9340. ⟨10.1021/acs.jmedchem.9b01578⟩
Journal of Medicinal Chemistry, American Chemical Society, 2019, 62 (20), pp.9339-9340. ⟨10.1021/acs.jmedchem.9b01578⟩
International audience
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3458dce9a9baf7d4d7aeec3ee6a28286
https://hal.science/hal-02526957
https://hal.science/hal-02526957
Autor:
Patrick Legembre, Amélie Fouqué
Publikováno v:
Methods in Molecular Biology ISBN: 9781493967780
CD95: Methods and Protocols
CD95: Methods and Protocols, 1557, pp.103-110, 2017, Methods in Molecular Biology, ⟨10.1007/978-1-4939-6780-3_10⟩
CD95: Methods and Protocols
CD95: Methods and Protocols, 1557, pp.103-110, 2017, Methods in Molecular Biology, ⟨10.1007/978-1-4939-6780-3_10⟩
International audience; CD95 is a plasma membrane receptor that belongs to the TNF receptor family (Itoh and Nagata, J Biol Chem 268(15):10932-10937, 1993; Trauth et al., Science 245(4915):301-305, 1989). Accumulating evidence indicate that this so-c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c9a9f608438fd72b6cacbf5d5a8d027
https://doi.org/10.1007/978-1-4939-6780-3_10
https://doi.org/10.1007/978-1-4939-6780-3_10
Autor:
Florent Dufour, Marine Malleter, Amélie Fouqué, Thierry Levade, Guillaume Poiroux, Aude Dupuy, Aubin Penna, Patrick Legembre, Kenji F. Shoji, Sébastien Tauzin, Valérie Edmond, Nathalie Théret, Olivier Micheau, Bruno Ségui, Ruth Rimokh, Odile Sergent
Publikováno v:
Oncogene
Oncogene, 2015, 34 (8), pp.996-1005. ⟨10.1038/onc.2014.55⟩
Oncogene, Nature Publishing Group, 2015, 34 (8), pp.996-1005. ⟨10.1038/onc.2014.55⟩
Oncogene, Nature Publishing Group, 2015, 34, pp.996-1005. 〈10.1038/onc.2014.55〉
Oncogene, 2015, 34 (8), pp.996-1005. ⟨10.1038/onc.2014.55⟩
Oncogene, Nature Publishing Group, 2015, 34 (8), pp.996-1005. ⟨10.1038/onc.2014.55⟩
Oncogene, Nature Publishing Group, 2015, 34, pp.996-1005. 〈10.1038/onc.2014.55〉
International audience; Epithelial-to-mesenchymal transition (EMT) promotes cell motility, which is important for the metastasis of malignant cells, and blocks CD95-mediated apoptotic signaling triggered by immune cells and chemotherapeutic regimens.
Autor:
Pierre Vacher, Marine Malleter, Yves Gouriou, Chi Li, L. Debure, Patrick Legembre, E. Lepvrier, Vanessa Delcroix, Amélie Fouqué, Mehdi Hammadi, Michel Ovize, Thomas Ducret
Publikováno v:
Cell Death and Differentiation
Cell Death and Differentiation, Nature Publishing Group, 2016, 23 (10), pp.1702-1716. ⟨10.1038/cdd.2016.61⟩
Cell Death and Differentiation, 2016, 23 (10), pp.1702-1716. ⟨10.1038/cdd.2016.61⟩
Cell Death and Differentiation, Nature Publishing Group, 2016, 23 (10), pp.1702-1716. ⟨10.1038/cdd.2016.61⟩
Cell Death and Differentiation, 2016, 23 (10), pp.1702-1716. ⟨10.1038/cdd.2016.61⟩
International audience; Metalloprotease-processed CD95L (cl-CD95L) is a soluble cytokine that implements a PI3K/Ca 2+ signaling pathway in triple-negative breast cancer (TNBC) cells. Accordingly, high levels of cl-CD95L in TNBC women correlate with p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::39cd4ba433ea04f7dd7ec841dc8ecc28
https://hal.archives-ouvertes.fr/hal-02378072/document
https://hal.archives-ouvertes.fr/hal-02378072/document
Autor:
Patrick Legembre, Sébastien Tauzin, Dominique Lagadic-Gossmann, Michael Monet, Laurent Counillon, Mallorie Poët, Auréa Cophignon, Pierre Vacher, Amélie Fouqué
Publikováno v:
Scientific Reports
Scientific Reports, Nature Publishing Group, 2016, 6 (1), ⟨10.1038/srep28008⟩
Scientific Reports, Nature Publishing Group, 2016, 6 (1), pp.28008. ⟨10.1038/srep28008⟩
Scientific Reports, 2016, 6 (1), pp.28008. ⟨10.1038/srep28008⟩
Scientific Reports, Nature Publishing Group, 2016, 6 (1), ⟨10.1038/srep28008⟩
Scientific Reports, Nature Publishing Group, 2016, 6 (1), pp.28008. ⟨10.1038/srep28008⟩
Scientific Reports, 2016, 6 (1), pp.28008. ⟨10.1038/srep28008⟩
Transmembrane CD95L (Fas ligand) can be cleaved to release a promigratory soluble ligand, cl-CD95L, which can contribute to chronic inflammation and cancer cell dissemination. The motility signaling pathway elicited by cl-CD95L remains poorly defined
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73c88afb96c07245370564c8e29c824d
https://hal.archives-ouvertes.fr/hal-03064894
https://hal.archives-ouvertes.fr/hal-03064894
Autor:
Yves Collette, Kenji F. Shoji, Olivier Delalande, Rémy Castellano, Mac Dinh Hung, Patrick Legembre, Marine Malleter, Mickael Jean, Emmanuelle Josselin, Pierre van de Weghe, Hariniaina Rampanarivo, Amélie Fouqué
Publikováno v:
Journal of Medicinal Chemistry
Journal of Medicinal Chemistry, American Chemical Society, 2015, 58 (16), pp.6559-6573. ⟨10.1021/acs.jmedchem.5b00991⟩
Journal of Medicinal Chemistry, 2015, 58 (16), pp.6559-6573. ⟨10.1021/acs.jmedchem.5b00991⟩
Journal of Medicinal Chemistry, American Chemical Society, 2015, 58 (16), pp.6559-6573. ⟨10.1021/acs.jmedchem.5b00991⟩
Journal of Medicinal Chemistry, 2015, 58 (16), pp.6559-6573. ⟨10.1021/acs.jmedchem.5b00991⟩
International audience; Constitutive activation of the PI3K/mTOR signaling pathway contributes to carcinogenesis and metastasis in most, if not all, breast cancers. From a chromene backbone reported to inhibit class I PI3K catalytic subunits, several
Autor:
Amélie Fouqué, Patrick Legembre
Publikováno v:
Cancer Immunology ISBN: 9783662440056
Cancer Immunology: A Translational Medicine Context, Second Edition
Cancer Immunology: A Translational Medicine Context, Second Edition, Springer International Publishing, pp.171-188, 2020, 9783030308452. ⟨10.1007/978-3-030-30845-2_11⟩
Cancer Immunology ISBN: 9783030308445
Cancer Immunology
Cancer Immunology: A Translational Medicine Context, Second Edition
Cancer Immunology: A Translational Medicine Context, Second Edition, Springer International Publishing, pp.171-188, 2020, 9783030308452. ⟨10.1007/978-3-030-30845-2_11⟩
Cancer Immunology ISBN: 9783030308445
Cancer Immunology
International audience; Unlabelled - Ovule number (ON) produced during flower development determines the maximum number of seeds per silique and thereby affects crop productivity; however, the genetic basis of ON remains poorly understood in oilseed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::373a38635cf93b7b7c1b375a2da90ce0
https://doi.org/10.1007/978-3-662-44006-3_9
https://doi.org/10.1007/978-3-662-44006-3_9
Publikováno v:
BBA-Biochimica et Biophysica Acta
BBA-Biochimica et Biophysica Acta, 2014, 1846 (1), pp.130-141. ⟨10.1016/j.bbcan.2014.04.007⟩
BBA-Biochimica et Biophysica Acta, Elsevier, 2014, 1846 (1), pp.130-141. ⟨10.1016/j.bbcan.2014.04.007⟩
BBA-Biochimica et Biophysica Acta, 2014, 1846 (1), pp.130-141. ⟨10.1016/j.bbcan.2014.04.007⟩
BBA-Biochimica et Biophysica Acta, Elsevier, 2014, 1846 (1), pp.130-141. ⟨10.1016/j.bbcan.2014.04.007⟩
International audience; Apoptosis is a fundamental process that contributes to tissue homeostasis, immune responses, and development. The receptor CD95, also called Fas, is a member of the tumor necrosis factor receptor (TNF-R) superfamily. Its cogna
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4eeef8e723d7f69ccec437ef2c5b88d0
https://hal-univ-rennes1.archives-ouvertes.fr/hal-01061290
https://hal-univ-rennes1.archives-ouvertes.fr/hal-01061290
Autor:
Amélie Fouqué, Olivier Delalande, Mickael Jean, Rémy Castellano, Emmanuelle Josselin, Marine Malleter, KenjiF. Shoji, Mac Dinh Hung, Hariniaina Rampanarivo, Yves Collette, Pierre van de Weghe, Patrick Legembre
Publikováno v:
Journal of Medicinal Chemistry; Aug2015, Vol. 58 Issue 16, p6559-6573, 15p
Publikováno v:
Scopus-Elsevier
Recent Patents on Anti-Cancer Drug Discovery
Recent Patents on Anti-Cancer Drug Discovery, Bentham Science Publishers, 2016, 11 (3), pp.283-296. ⟨10.2174/1574892811666160519113731⟩
Recent Patents on Anti-Cancer Drug Discovery, 2016, 11 (3), pp.283-296. ⟨10.2174/1574892811666160519113731⟩
Recent Patents on Anti-Cancer Drug Discovery
Recent Patents on Anti-Cancer Drug Discovery, Bentham Science Publishers, 2016, 11 (3), pp.283-296. ⟨10.2174/1574892811666160519113731⟩
Recent Patents on Anti-Cancer Drug Discovery, 2016, 11 (3), pp.283-296. ⟨10.2174/1574892811666160519113731⟩
International audience; Background: Constitutive activation of the PI3K/mTOR signaling pathway is observed in most, if not all, breast cancers. Accordingly, many PI3K and/or mTOR inhibitors have entered clinical trials, and completed studies should s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f35aa09e66ea088903db18535a1e9932
http://www.scopus.com/inward/record.url?eid=2-s2.0-84983781386&partnerID=MN8TOARS
http://www.scopus.com/inward/record.url?eid=2-s2.0-84983781386&partnerID=MN8TOARS